1Lukyanchuk VV, Friess H, KleeffJ, et al. Detection of circulating tumor cells by cytokeratin 20 and prostate stem cell antigen RT- PCR in blood of patients with gastrointestinal cancer [ J ]. Anticancer Res,2003;23(3) :2711 ～ 6
2De Luca A, Pignata S, Casanassimi A, et al. Detection of circulating tumor cells in carcinoma patients by a novel epidermal growth factor receptor reverse transcription- PCR assay [ J]. Clin Cancer Res, 2000;6(4): 1439 ～ 44
3Jotsuka T, Okumura Y, Nakano S, et al. Persistent evidence of circulating tumor cells detected by means of RT - PCR for CEA mRNA predicts early relapse: a prospective study in node- negative breast cancer[J]. Surgery, 2004;135(4):419～26
4Kojima N, Kunieda K, Matsui K, et al. Evaluation of carcinoembryonic antigen mRNA in living, necrotic, and apoptotic gastric cancer cells by reverse transcriptase - polymerase chain reaction [ J ]. Surg Today,2003;3(11):839～46
5Sapi E, Okpokwasili NI, Rutherford T. Detection of telomerase - positive circulating epithelial cells in ovarian cancer patients [J]. Cancer Detect Prey, 2002;26(2): 158 - 167
6Leon SA, Shapiro B, Sklaroff DM, et al. Free DNA in the serum of cancer patients and the effent of therapy [J]. Cancer Res, 1997;37(3) :646 - 650
7Shapiro B, Chakrabarty M, Cohn EM, et al. Determination of circulating DNA levels in patients with benign or malignant gastrointestinal disease [J]. Cancer, 1983;51(1):2116-2120
8Nawroz- Danish H, Eisenberger CF, Yoo GH, et al. Microsatellite analysis of serun DNA in patients with head and neck cancer [J]. Int J Cancer, 2004; 111(1) :96 - 100
9Mulcahy HE, Lyautey J, Lederrey C, et al. A Prospective study of K - ras gene mutation in the plasma of pancreatic cancer patients [J].Clin Cancer Res, 1998;4(2) :271 - 275
10Wyld DK, Selby P, Perren TJ, et al. Detection of colorectal cancer cells in peripheral blood by reverse- transcriptase polymerase chain reaction for cytokeratin 20 [J]. Int J Cancer, 1998;79(3) :288 - 93
4Lonning PE, Taylor PD, Anker G, et al. High - dose estrogen treatment in post - menopausal breast cancer patients heavi- ly exposed to endocrine therapy [ J ]. Breast Cancer ResTreat,2001,67(2) :111 - 116.
5Ellis M J, Dehdahti F, Kommareddy A, et al. A randomized phase 2 trial of low dose ( 6 mg daily) versus high dose ( 30 mg daily)estradiol for patients with estrogen receptor posi- tive aromatase inhibitor resistant advanced breast cancer [ J ]. Cancer Res,2009,302 (7) :774 - 780.
6Shu Zhao, Qingyuan Zhang. The prognostic role of circulat- ing tumor cells ( CTCs ) detected by RT - PCR in breast cancer: a meta - analysis of published hterature [ J ]. Breast Cancer Res Treat,2011,130 ( 3 ) : 809 - 816.
7Pachmann K, Camara O, Kavallaris A, et al. Monitoring the response of circulating epithelial tumor cells to adjuvant chemotherapy in breast cancer allows detection of patients at risk of early relapse[ J]. Clin Oncol,2008,26 (8):1208 - 2015.
8Mitra Tewes, Bahfiye Aktas, Anja Welt, et al. Molecular pro- filing and predictive value of circulating tumor ceils in pa- tients with metastatic breast cancer:an option for monitoring response to breast cancer related therapies[ J ]. Breast Canc- er Res Treat,2009,115 ( 3 ) :581 - 590.
9Serrano M J, S6nchez - Rovira P, Delgado - Rodriguez M, et al. Detection of circulating tumor cells in the context of treatment:Prognostic value in breast cancer[ J ]. Cancer Biol Ther,2009,8 ( 8 ) :671 - 675.
10Anker P, Stroun M. Circulating DNA in plasma or serum [J]. Medicina(B Aires) ,2000,60(5 Pt 2) :699 -702.
